Your browser doesn't support javascript.
loading
Maternal Marijuana Exposure, Feto-Placental Weight Ratio, and Placental Histology.
Metz, Torri D; Allshouse, Amanda A; Pinar, Halit; Varner, Michael; Smid, Marcela C; Hogue, Carol; Dudley, Donald J; Bukowski, Radek; Saade, George R; Goldenberg, Robert L; Reddy, Uma; Silver, Robert M.
Afiliação
  • Metz TD; University of Utah Health, Salt Lake City, Utah.
  • Allshouse AA; University of Utah Health, Salt Lake City, Utah.
  • Pinar H; Brown University, Providence, Rhode Island.
  • Varner M; University of Utah Health, Salt Lake City, Utah.
  • Smid MC; University of Utah Health, Salt Lake City, Utah.
  • Hogue C; Emory University, Atlanta, Georgia.
  • Dudley DJ; University of Virginia School of Medicine, Charlottesville, Virginia.
  • Bukowski R; University of Texas at Austin, Dell Medical School, Austin, Texas.
  • Saade GR; University of Texas Medical Branch, Galveston, Texas.
  • Goldenberg RL; Columbia University, New York City, New York.
  • Reddy U; Yale University, New Haven, Connecticut.
  • Silver RM; University of Utah Health, Salt Lake City, Utah.
Am J Perinatol ; 39(5): 546-553, 2022 04.
Article em En | MEDLINE | ID: mdl-32971561
ABSTRACT

OBJECTIVE:

Marijuana use is associated with placenta-mediated adverse pregnancy outcomes including fetal growth restriction, but the mechanism remains uncertain. The objective was to evaluate the association between maternal marijuana use and the feto-placental weight ratio (FPR). Secondarily, we aimed to compare placental histology of women who used marijuana to those who did not. STUDY

DESIGN:

This was a secondary analysis of singleton pregnancies enrolled in a multicenter and case-control stillbirth study. Prior marijuana use was detected by electronic medical record abstraction or cord homogenate positive for 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid. Prior tobacco use was detected by self-report or presence of maternal serum cotinine. Stillbirths and live births were considered separately. The primary outcome was FPR. Association of marijuana use with FPR was estimated with multivariable linear modeling adjusted for fetal sex, preterm birth, and tobacco use. Comparisons between groups for placental histology were made using Chi-square and stratified by live birth and stillbirth, term and preterm deliveries, and fetal sex.

RESULTS:

Of 1,027 participants, 224 were stillbirths and 803 were live births. Overall, 41 (4%) women used marijuana during the pregnancy. The FPR ratio was lower among exposed offspring but reached statistical significance only for term stillbirths (mean 6.84 with marijuana use vs. mean 7.8 without use, p < 0.001). In multivariable modeling, marijuana use was not significantly associated with FPR (p = 0.09). There were no differences in histologic placental features among those with and without marijuana use overall or in stratified analyses.

CONCLUSION:

Exposure to marijuana may not be associated with FPR. Similarly, there were no placental histologic features associated with marijuana exposure. Further study of the influence of maternal marijuana use on placental development and function is warranted to better understand the association between prenatal marijuana use and poor fetal growth. KEY POINTS · Maternal marijuana exposure was not associated with the feto-placental weight ratio.. · Marijuana exposure was not associated with differences in placental histology.. · Concerning trend toward lower feto-placental weight ratios among marijuana-exposed stillbirths..
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis / Nascimento Prematuro Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis / Nascimento Prematuro Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article